PLAY PODCASTS
The Power in Connecting Rare Disease Patient Groups - Dr. Rick Thompson, CEO of Beacon for Rare Diseases
Episode 377

The Power in Connecting Rare Disease Patient Groups - Dr. Rick Thompson, CEO of Beacon for Rare Diseases

Raise the Line · Dr. Rick Thompson, Shiv Gaglani

May 4, 202329m 44s

Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

We've heard many stories on Raise the Line about patients and their family members who, upon getting a rare disease diagnosis, build a non-profit organization from scratch to boost advocacy and research for the condition in question. This is obviously a pretty big hill to climb for people with no background in such things. Well, today we're going to learn about Beacon for Rare Diseases, a UK non-profit designed to provide the expertise and support needed to get a rare disease patient group off the ground, and to connect these groups with each other for the purpose of mutual education and support. “What we've seen is that people forming and building patient organizations can help really trigger a new community around that, and help drive the field forward,” Beacon CEO Dr. Rick Thompson tells host Shiv Gaglani. “What we want to do as an organization is help those patient groups form, to grow, and to professionalize their work.” Tune in to find out how Dr. Thompson’s background in evolutionary biology, research and education impacts his work at Beacon, why rare diseases should be approached in the same way as cancer, and his interest in repurposing existing drugs for use in treating rare diseases. 

Mentioned in this episode:  https://www.rarebeacon.org/

 

If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Topics

drug costspharmacy benefit managersdrug developmentcontinuing educationjohns hopkins universityomicrondoctorsmedical degreesdrug repurposingcoronavirushome caredigital healthhealth insurancewearablesfrontline providersosmosis from elsevierpfizerfdagovernment policymedicareraise the lineblack bone diseasevirusmachine learningeducation innovationpharmaceuticalshospital staysinterviewnursing schoolflatten the curvemichael carreseelsevieraihealthcare entrepreneursnursing cmenursesprimary carehealthcare capacityhealthcare reformbig pharmaastra zenecacovid-19rare disordershealthcare workforceexpertsspace repetitionmedical educationnursing shortagemedicaidlearning sciencelearning sciencegene editingvalue-based caretechnologyflipped classroommedicare advantagenursing educationsolutionsphysician shortagepatient groupsprovider burnoutcdcepidemicosmosisdelta variantremote monitoringhealthcare systemmark cubanosmosis.orgdecision supportdavid fajgenbaumrare diseasesvirus outbreakonline educationallied health professionspublic policycovid19edtechshiv gaglanimodernaphysician assistant educationbeacon for rare diseasescambridgevivian leechelsea clintonpodcastsnursing degreehospital systemspublic healthdr. ashish jhavaccineseric topolyear of the zebradental educationtestingcenters for disease controlhealth professionspandemicjohnson & johnsontelehealth